Nova BioLabs is a pre-revenue Colorado S-corp based in Arvada, CO. We seek to improve long-term cancer survival rates and quality-of-life by driving adoption of next-generation sequencing as a routine test, as well as making cancer-care truly personalized and patient-centric. We aim to offer a personalized tumor recurrence test that is non-invasive, one of the very first such tests that is FDA-approved, and 10x lower cost than current offerings.